Evidence map›Paper›PMID 41399067›Full record

ArticleBeijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences2025

[Role of the SII and SIRI in risk prediction, disease activity assessment, and prog-nostic evaluation of Behçet disease uveitis].

Yajing Gao, Zhengfang Li, Mengsi Ma, Lijun Wu

Abstract readEnglish Abstract
PubMed Full text at PMC
In one paragraph

Article in Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yajing GaoDepartment of Rheumatology and Immunology, People's Hospital of Xinjiang Uygur Autonomous Region, Uygur 830000, China.
Zhengfang LiDepartment of Rheumatology and Immunology, People's Hospital of Xinjiang Uygur Autonomous Region, Uygur 830000, China.
Mengsi MaDepartment of Rheumatology and Immunology, People's Hospital of Xinjiang Uygur Autonomous Region, Uygur 830000, China.
Lijun WuDepartment of Rheumatology and Immunology, People's Hospital of Xinjiang Uygur Autonomous Region, Uygur 830000, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo evaluate the association of systemic immune-inflammation index (SII) and systemic inflammatory response index (SIRI) with Behçet disease uveitis (BU), and to assess their predictive value for inflammatory activity and clinical prognosis in BU patients.

methodsThere were 194 patients diagnosed with Behçet disease (BD) and 122 healthy controls. The BD patients were classified into two subgroups based on disease activity: An active phase cohort (

resultsSII and SIRI levels were significantly elevated in BD patients with ocular and vascular manifestations compared to those with stable disease (

conclusionSII and SIRI may serve as potential clinical indicators for predicting inflammatory activity and prognosis in BD patients with uveitis. SII, in particular, demonstrates superior predictive performance for BU onset and disease activity, providing a basis for early identification of high-risk patients and clinical decision-making.

Indexed as

Behcet SyndromeUveitisAdultCase-Control StudiesFemaleHumansInflammationMaleMiddle AgedPrognosisSeverity of Illness IndexYoung AdultBehçet disease uveitisPrognostic assessmentSystemic immune inflammation indexSystemic inflammatory response index

Identifiers

PMID41399067
PMCPMC12711395

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.